Select Page

News

FLIGHTLINES

Vaccine and Booster Shot Information:
This website link offers a great overview of the current recommendations for the COVID-19 vaccine, including links to all provinces and territories. You can find information about vaccine and booster shot eligibility, making appointments, important considerations for immunocompromised patients, and general information.
https://www.canada.ca/en/public-health/services/diseases/coronavirus-disease-covid-19/vaccines/how-vaccinated.html#a2
The below document released by the Ontario Ministry of Health offers comprehensive information about the initial COVID 19 vaccine series and the rational and recommendations for the COVID-19 Booster shot. There is also an extensive list of immunosuppressive medications that warrant a 3rd dose of whichever vaccine one chooses to get.
https://www.health.gov.on.ca/en/pro/programs/publichealth/coronavirus/docs/vaccine/COVID-19_vaccine_third_dose_recommendations.pdf

CAMATA 2021 AGM Meeting

We are planning our annual general meeting via zoom on October 13, 2021 at 7pm central time.

Please RSVP to info@camata.ca and the zoom login information will be sent to you.

If you would like to submit agenda items, please feel free to email them to:
info@camata.ca by September 30, 2021.

We hope you will join us.

Level 1 Course May 19 & 20, 2021 via ZOOM

The CAMATA Air Medical Training Program Level I will be held via zoom platform on May 19 & 20th, 2021 from 0830 - 1700 daily (Central Daylight Time).  The course provides the following:a) Basic Air Medical information for health care providers...

FLIGHTLINES

COVID 19 Vaccine Information Part 2: Vaccines and their role in stopping the pandemic Aproval Process Pfizier:The Pfizer vaccine was the first to be approved in Canada and initially show to have an efficacy of 95%. Age range for administration is 16 years and above....

FLIGHTLINES

Hi there! I thought for this quarter I would post some information about the covid vaccine. I will do this in 3 parts

COVID 19 Vaccine Information Part 1:

The Trial Process:

Vaccines are generally tested on animals before entering into a 3-phase clinical trial process. Once all 3 phases of the trial process are complete, collected data can be submitted to Health Canada for review. See below for additional information.

http://www.bccdc.ca/health-info/diseases-conditions/covid-19/covid-19-vaccine/vaccine-approval-process

Clinical trials are an essential component to the approval process of safe vaccines. Although there are approximately 150 clinical trials globally, only those that meet rigorous Canadian testing standards are suitable for distribution in Canada. Due to the pressing nature of developing a vaccine, manufacturers are using different approaches to fast tracking development. For additional information see the below link:

https://www.canada.ca/en/public-health/services/diseases/2019-novel-coronavirus-
infection/prevention-risks/covid-19-vaccine-treatment/clinical-trials.html

The below link offers an overview of 150 COVID-19 that are ongoing throughout Canada
and Internationally and is being updated weekly. Trial topics are vast and include vaccine approval and studies pertaining to the long term effects of the virus. A synopsis and link are provided for each.

https://clinicaltrials.gov/ct2/who_table

The Part 2 will be related to the specific vaccines that have been approved in Canada.

Jen